Cardiovascular Risk Assessment and Dynamic Monitoring-based Prevention Trial

Recruiting now · Not applicable

Conditions studied: Cardiovascular Diseases

In brief

The CRITICALLY study is a cluster randomized trial that will evaluate the effectiveness of a risk-based dynamic monitoring strategy for the primary prevention of cardiovascular high-risk Chinese adults.

Key facts

Study ID

NCT05919056

Run by

Peking University

People needed

22032

Starts

2023-07-06

Expected to finish

2028-07-01

Last updated by the study team

2024-11-15

Who can join

Age: 40 and older, up to 79. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Residents in the Yinzhou District have a unique health ID;
• Aged 40 to 79 years at the baseline enrollment;
• With high risk of cardiovascular disease evaluated by the 2019 WHO laboratory-based risk models (10-year risk≥10%);

You may not qualify if…

• Have a history of coronary heart disease, stroke or heart failure;
• Patients with a diagnosis of cancer;
• Refused to provide written informed consent

Where it is running

• Yinzhou District Center for Disease Control and Prevention — Ningbo, Zhejiang, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.